SHARDACROP Sharda Cropchem Q4 FY26 results (Jan–Mar 2026) and concall
Sharda Cropchem delivered its best-ever annual performance in FY26, with robust revenue and PAT growth, driven by strong volume and expanded margins. Q4 FY26 continued this positive trend, showcasing significant EBITDA and PAT increases. The company maintains a strong financial position, being debt-free with substantial cash reserves and improved working capital. While positive forex impact aided growth, negative price/product mix and minor degrowth in NAFTA were noted, alongside unrealized forex losses in Q4.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 12.9%, net profit up 56.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 777 | 929 | 1,829 | 985 | 929 +20% | 1,289 +39% | 2,065 +13% |
| EBITDA | 90 | 115 | 303 | 215 | 133 +48% | 241 +110% | 487 +61% |
| Net profit | 42 | 31 | 204 | 143 | 74 +76% | 145 +368% | 319 +56% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
